Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kort (Enschede, Netherlands), M. Tiggeloven (Enschede, Netherlands), M. Brusse-Keizer (Enschede, Netherlands), H. Schouwink (Enschede, Netherlands), F. De Jongh (Enschede, Netherlands), E. Citgez (Enschede, Netherlands), J. Gerritsen (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands). Detecting subtypes of non-small cell lung cancer by electronic nose.. 1761

Member's Comments

No comment yet.

Related content which might interest you: Detection of non-small cell lung cancer by an electronic nose. Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Update on nonsmall cell lung cancer Source: Eur Respir Rev 2010 19: 173-185 Year: 2010 Gene modules in non-small cell lung cancer Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Clinical features of nonsmall cell lung cancer cases Source: Eur Respir J 2002; 20: Suppl. 38, 75s Year: 2002 A non-small cell lung cancer modelling by endogenous κ-ras manipulation Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection Year: 2005 Radio(chemo)therapy in locally advanced nonsmall cell lung cancer Source: Eur Respir Rev 2015; 25: 65-70 Year: 2016 New treatment options for nonsmall cell lung cancer and small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006 Treatment of  non-small cell lung cancer (NSCLC) - the state of the art and beyond Source: International Congress 2017 – State of the art session: "Lung cancer" Year: 2017 Biological therapies in nonsmall cell lung cancer Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016 Year: 2017 Metastatic disease in non-small cell lung cancer: is it all the same? Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Implementation of PD-L1 analysis among patients with non-small cell lung cancer in a single center. Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 Features of N-staging in left-sided non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Second line therapy for advanced non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Soluble non-invasive markers in non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005 Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006